Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis
Journal article, Peer reviewed
Published version

Åpne
Permanent lenke
https://hdl.handle.net/11250/2739933Utgivelsesdato
2020Metadata
Vis full innførselSamlinger
- Department of Clinical Medicine [2192]
- Registrations from Cristin [11244]
Sammendrag
Aqueous misdirection syndrome is a rare, incompletely understood, sight-threatening eye condition that is difficult to diagnose and treat. We present a case of simultaneous bilateral aqueous misdirection following the administration of certolizumab in a 41-year-old women with rheumatoid arthritis and no known risk factors. To our knowledge, aqueous misdirection has not previously been associated with the use of tumour necrosis factor-alpha inhibitors.